Company Search:
Advanced Search
Sponsored Links
BGI Genomics Co Ltd Company Snapshot
BGI Genomics Co Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares BGI Genomics Co Ltd with three other miscellaneous service companies in Asia: Hutchison China Meditech Limited (2017 sales of 1.62 billion Chinese Renmimbi [US$240.31 million] of which 69% was Is Operating - Prescription Drugs PRC), Takara Bio Inc of Japan (29.38 billion Japanese Yen [US$264.67 million] of which 90% was Bio support), and Chabiotech Co Ltd which is based in South Korea (418.88 billion Korean Won [US$371.97 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BGI Genomics Co Ltd
  Stock Performance Chart for BGI Genomics Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 67.80
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 12.7%  
4 Weeks 6.8%   52 Weeks -55.1%  
BGI Genomics Co Ltd Key Data:
  Ticker: 300676 Country: China
  Exchanges: SZN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 2,095,544,271
(Year Ending Jan 2018).
Employees: 2,846
  Currency: Chinese Renmimbi Market Cap: 27,126,780,000
  Fiscal Yr Ends: December Shares Outstanding: 400,100,000
  Share Type: Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.